After a review of existing data, the Endocrine Society has released several recommendations and statements regarding the treatment of symptoms associated with estrogen depletion following breast cancer.
...
Aromatase inhibitor-associated musculoskeletal symptoms frequently occur in women receiving treatment for breast cancer. In a recent randomized control trial, researchers assessed the efficacy of vitamin D...
The US Food and Drug Administration recently approved a new treatment option for patients with early stage HER2-overexpressed/amplified breast cancer. For recommended dosage and common adverse events, read...
Approximately 70% of pregnant women experience pelvic girdle pain (PGP). Therefore, the American Physical Therapy Association has released a new guideline with recommendations for PGP management.
Preterm preeclampsia is a significant cause of maternal and perinatal complications and death during pregnancy. A recent study evaluated the effects of daily aspirin use during pregnancy on preterm...
The American College of Obstetricians and Gynecologists has recently released updated clinical guidelines on breast cancer screening in women facing average risk.
The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.
